CD158 antigen like family member B2, CD158 antigen-like family member B2, CD158b, CD158b2, GL183, KI2L3_HUMAN, Killer cell immunoglobulin like receptor two domains long cytoplasmic tail 3, Killer cell immunoglobulin-like receptor 2DL3, Killer inhibitory receptor cl 2-3, Killer inhibitory receptor CL2 3, KIR 023GB, KIR-023GB, KIR-K7b, KIR-K7c, KIR023GB, KIR2DL3, KIR2DS5, KIRCL23, MHC class I NK cell receptor, Natural killer associated transcript 2, Natural killer cell inhibitory receptor KIR2DL3, Natural killer-associated transcript 2, NKAT, NKAT-2, NKAT2, NKAT2a, NKAT2b, p58, p58 natural killer cell receptor clone CL 6, p58 natural killer cell receptor clone CL-6, p58 NK Receptor, p58 NK receptor CL 6, p58 NK receptor CL-6, p58.2 MHC class I specific NK receptor, p58.2 MHC class-I-specific NK receptor
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several framework genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.
Applications
Suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence/Immunocytochemistry and ELISA. Other applications not tested.
Recommended Dilution
Western Blot: 1:500-1:2000, incubate membrane with diluted primary antibody in TBS, 5% milk, 0.1% Tween 20 at 4°C with gentle shaking, overnight. Immunohistochemistry: 1:50-1:200 Immunofluorescence (IF-IC): 1:100-1:500 ELISA (peptide): 1:20,000-1:40,000 Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Immunogen
Synthetic peptide corresponding to human KIR2DL3.
Form
Supplied as a liquid in PBS, pH 7.4, 0.02% sodium azide, 50% glycerol.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes endogenous levels of total human KIR2DL3.